Breaking
Potter helps England find magic but World Cup playoff format needs rethink | Tom Garry Who am I? Plus today's other quizzes Bank of England and IMF bosses warn of cyber threat to trust in financial system Ukrainian soldiers in combat have access to Starlink satellite internet restricted A dominatrix and her tightly bound client: Giada Ripa’s best photograph Guardiola's return, Man City's defiance - and a game of glorious chaos Dog that hunts invasive 'sea vomit' honoured as animal of the year Eight states sue OpenAI over ChatGPT’s alleged harms to users Kentucky police arrest 8 in child abuse, trafficking and rape investigation ‘Like, really, really shocked’: why are so many people riffing on this sheep’s sex appeal?
NEWSREEL
The day, in 30-second reels.
--:--:--
Tech / Reel
Tech · Video brief

Intero Biosystems wants drugmakers to test on mini human intestines, not animals

Intero Biosystems is revolutionizing drug testing by developing human intestinal organoids that better predict human responses, unlike traditional animal testing. Their product, GastroScreen, is designed for pharmaceutical and biotech firms...

TechCrunch· Oct 15, 2026 · 12:20 AM · 2 views

Video won't play? Watch on YouTube →

Intero Biosystems is revolutionizing drug testing by developing human intestinal organoids that better predict human responses, unlike traditional animal testing. Their product, GastroScreen, is designed for pharmaceutical and biotech firms to enhance drug efficacy and safety. Full story and more reels: https://newsreel.video #news #breaking #healthcare #biotechnology #drugtesting #innovation

Originally reported by TechCrunch. Read the full story →

More in Tech

Tech Tech
Tech

Bank of England and IMF bosses warn of cyber threat to trust in financial system

The Guardian· 1 hour ago
Tech Tech
Tech

Eight states sue OpenAI over ChatGPT’s alleged harms to users

NBC News· 1 hour ago
Tech Tech
Tech

Eight states accuse OpenAI of coaching children to harm themselves in lawsuit

The Guardian· 2 hours ago

0 Comments

No comments yet. Be the first.